Other approaches that are in development include fibroblast growth factor (FGF) mimetics such as FGF21-targeting candidates ...

Tumor cells circulating in the blood are the germ cells of breast cancer metastases. They are very rare and have not been ...

FibroBiologics, Inc. (Nasdaq: FBLG) announced the successful closure of the second $5 million tranche of financing as part of its Standby Equity Purchase Agreement (SEPA) with YA II PN, LTD., an ...

Study findings spotlight a highly potent source of Ebola virus shedding with the potential for person-to-person transmission.

FibroBiologics, Inc. ( (FBLG) ) has issued an announcement.

Tumor cells circulating in the blood are the “germ cells” of breast cancer metastases. They are very rare and could not be propagated in the culture dish until now, which made research into therapy ...

FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics”), a clinical-stage biotechnology company with 160+ patents issued and ...

FibroB (Nasdaq: FBLG) ("FibroBiologics”), a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic ...

Discover the latest on Akero Therapeutics, Inc., a biotech firm focusing on metabolic balance therapies, with a market cap of ...

Tumor cells circulating in the blood are the "germ cells" of breast cancer metastases. They are very rare and could not be propagated in the culture dish until now, which made research into therapy ...

(NASDAQ:ETNB – Get Free Report)‘s stock had its “overweight” rating reiterated by equities research analysts at Cantor ...

After studying the axolotl for 8 years, researchers are developing a line of cosmeceutical and over-the-counter products ...